1 Min Read
April 19 (Reuters) - Synthetic Biologics Inc:
* Synthetic Biologics reports preclinical data demonstrating SYN-005 provides protection from Pertussis in neonatal animal study Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.